1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. RAPPORT THERAPEUTICS INC.
Rapport Therapeutics Inc. XNAS: RAPP

Rapport Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

Read More
28.93 2.05 (7.63%)
31.56% Fall from 52W High
415.3K
XNAS Volume

XNAS 31 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Rapport Therapeutics Inc. is on 07 Nov 2025 for the purpose of Rapport Therapeutics Inc Third Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
8.7 / 100
Momentum Score
Technically Bullish
77.8 / 100
Analyst Price Target
No estimates available

16

S

7

W

6

O

0

T

SWOT Analysis

Rapport Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..